The influence of metabolic syndrome coexistence on the prognosis of patients with heart failure without atrial fibrillation. Analysis of Polish data from the pilot survey for the ESC Heart Failure Registry

MeSH terms

• Adult
• Aged
• Anti-Arrhythmia Agents / therapeutic use
• Comorbidity
• Female
• Heart Failure / epidemiology*
• Heart Failure / therapy*
• Humans
• Male
• Metabolic Syndrome / epidemiology*
• Metabolic Syndrome / therapy
• Middle Aged
• Pilot Projects
• Poland
• Population Surveillance*
• Prognosis
• Registries